Security key
071705107
- Security type / class
- Equity / COMMON SHARES
- Total 13F shares
- 40,725,425
- Total 13F value
- $591,298,221
- Share change
- +3,123,392
- Put/Call ratio
- 209%
- SEC-reported price per share
- $14.52
- Number of holders
- 89
- Value change
- +$44,634,723
- Number of buys
- 55
- Number of sells
- 36
Open additional details 1 more signal available
Report period
Q2 2024
Institutions
89
Top holders
10
BLCO full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Bausch & Lomb Corp SEC filings
Bausch & Lomb Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 071705107
Recent filing periods:
Ownership snapshot
Top reported holders of BLCO - Bausch & Lomb Corp - COMMON SHARES (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Bausch Health Companies Inc.
Disclosed value leader
Bausch Health Companies Inc.
Comparable rows
0/15
Latest evidence
31 Mar 2024
3/4/5
13F
Highest disclosed value: $5,296,270,910
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Bausch Health Companies Inc. has the largest disclosed position value at $5.3B.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Bausch Health Companies Inc.'s linked filing trail.
Disclosed position value
Top 5
Bausch Health Companies Inc.
$5.3B
FIL Ltd
$141.6M
GOLDENTREE ASSET MANAGEMENT LP
$81.58M
Maple Rock Capital Partners Inc.
$64.79M
Carl C. Icahn
$60.55M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Bausch Health Companies Inc. |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$5,296,270,910
310,449,643 shares
|
— | 01 Jun 2022 |
| FIL Ltd |
13F
Company
|
—
class O/S missing
|
$141,603,960
8,185,200 shares
|
— | 31 Mar 2024 |
| GOLDENTREE ASSET MANAGEMENT LP |
13F
Company
|
—
class O/S missing
|
$81,583,842
4,715,829 shares
|
— | 31 Mar 2024 |
| Maple Rock Capital Partners Inc. |
13F
Company
|
—
class O/S missing
|
$64,789,573
3,745,062 shares
|
— | 31 Mar 2024 |
| Carl C. Icahn |
13F
Individual
|
—
class O/S missing
|
$60,550,000
3,500,000 shares
|
— | 31 Mar 2024 |
| Joseph C. Papa |
3/4/5
CEO & Chairman, Director
|
—
mixed-class rows
|
$37,684,665
2,340,353 shares
mixed-class rows
|
— | 05 May 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
89
Shares
40,725,425
Rows available
89
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
84
Q2 2024 holders
89
Holder diff
5
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend